Fortin Davide, Di Beo Vincent, Massin Sophie, Bisiou Yann, Carrieri Patrizia, Barré Tangui
University Paris 1 Sorbonne, Paris, France.
Aix Marseille University, INSERM, IRD, SESSTIM, Sciences Economiques & Sociales de la Santé & Traitement de l'Information Médicale, ISSPAM, Marseille, France.
Front Psychiatry. 2022 Mar 17;13:829944. doi: 10.3389/fpsyt.2022.829944. eCollection 2022.
Although cannabis use is common in France, it is still criminalized. Cannabidiol (CBD) products, including CBD-rich cannabis, are legally available. Although previous results suggested that CBD may have benefits for people with cannabis use disorder, there is a lack of data on cannabis users who use CBD to reduce their cannabis consumption. We aimed to identify (i) correlates of this motive, and (ii) factors associated with successful attempts to reduce cannabis use.
A cross-sectional online survey among French-speaking CBD and cannabis users was conducted. Logistic regressions were performed to identify correlates of using CBD to reduce cannabis consumption and correlates of reporting a large reduction.
Eleven percent ( = 105) of our study sample reported they primarily used CBD to reduce cannabis consumption. Associated factors included smoking tobacco cigarettes (adjusted odds ratio (aOR) [95% confidence interval (CI)] 2.17 [1.3-3.62], = 0.003) and drinking alcohol (aOR [95%CI] 1.8 [1.02-3.18], = 0.042). Of these 105, 83% used CBD-rich cannabis to smoke, and 58.7% reported a large reduction in cannabis consumption. This large reduction was associated with non-daily cannabis use (aOR [95%CI] 7.14 [2.4-20.0], < 0.001) and daily CBD use (aOR [95%CI] 5.87 [2.09-16.47], = 0.001). A reduction in cannabis withdrawal symptoms thanks to CBD use was the most-cited effect at play in self-observed cannabis reduction.
Cannabis use reduction is a reported motive for CBD use-especially CBD-rich cannabis to smoke-in France. More studies are needed to explore practices associated with this motive and to accurately assess CBD effectiveness.
尽管在法国大麻使用很普遍,但它仍被认定为犯罪行为。包括富含大麻二酚(CBD)的大麻在内的CBD产品在法律上是可以获取的。尽管先前的研究结果表明CBD可能对患有大麻使用障碍的人有益,但对于使用CBD来减少大麻消费的大麻使用者,仍缺乏相关数据。我们旨在确定:(i)这种动机的相关因素,以及(ii)与成功减少大麻使用相关的因素。
对说法语的CBD和大麻使用者进行了一项横断面在线调查。进行逻辑回归分析以确定使用CBD减少大麻消费的相关因素以及报告大麻使用量大幅减少的相关因素。
我们研究样本中的11%(n = 105)报告称他们主要使用CBD来减少大麻消费。相关因素包括吸烟(调整后的优势比(aOR)[95%置信区间(CI)]为2.17 [1.3 - 3.62],P = 0.003)和饮酒(aOR [95%CI]为1.8 [1.02 - 3.18],P = 0.042)。在这105人中,83%使用富含CBD的大麻吸烟,58.7%报告大麻消费量大幅减少。这种大幅减少与非每日使用大麻(aOR [95%CI]为7.14 [2.4 - 20.0],P < 0.001)和每日使用CBD(aOR [95%CI]为5.87 [2.09 - 16.47],P = 0.001)有关。在自我观察到的大麻减少中,使用CBD后大麻戒断症状的减轻是最常被提及的起作用的因素。
在法国,减少大麻使用是报告的使用CBD的动机——尤其是使用富含CBD的大麻吸烟。需要更多研究来探索与这种动机相关的行为,并准确评估CBD的有效性。